Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Osteoarthritis Cartilage ; 24(2): 325-34, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26327449

RESUMO

OBJECTIVE: Norepinephrine (NE) was measured in synovial fluid of trauma patients and sympathetic nerve fibers were detected in healthy and osteoarthritic (OA) joint tissues indicating that cartilage pathophysiology might be influenced by sympathetic neurotransmitters. The aim of this study was to elucidate the mostly unknown role of NE in OA chondrocyte metabolism and inflammatory responses. METHODS: Articular cartilage was received after total knee replacement surgery from OA patients. Expression of adrenergic receptors (AR) and tyrosine hydroxylase (TH) was tested with end point polymerase chain reaction (PCR) and immunohistochemistry. 3-dimensional (3D) cell cultures were employed to analyze effects of NE on chondrocyte cell metabolism and the expression of interleukins (ILs), matrix metalloproteases (MMPs), tissue inhibitor of metalloproteases (TIMPs), glycosaminoglycan (GAG) and collagen II under non- and inflammatory conditions. Chondrocyte monolayer cultures were used to specify AR subtypes, to analyze cell cycle distribution and to determine catecholamines in cell culture supernatants. RESULTS: AR subtypes and TH were detected in chondrocytes, whereas NE was not released in measurable amounts. 10(-6) M NE reversed IL-1ß induced changes in IL-8, MMP-13, GAG and collagen II expression/production indicating for ß-AR signaling. Additionally, NE caused cell cycle slow down and decreased proliferation via ß-AR signaling. 10(-8) M NE increased the number of proliferating cells and induced apoptosis via α1-AR signaling. CONCLUSIONS: NE affects chondrocytes from OA cartilage regarding inflammatory response and its cell metabolism in a dose dependent manner. The sympathetic nervous system (SNS) may have a dual function in OA pathology with preserving a stable chondrocyte phenotype via ß-AR signaling and OA pathogenesis accelerating effects via α-AR signaling.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Condrócitos/efeitos dos fármacos , Metaloproteinases da Matriz/efeitos dos fármacos , Norepinefrina/farmacologia , Osteoartrite do Joelho/metabolismo , Receptores Adrenérgicos/efeitos dos fármacos , Inibidores Teciduais de Metaloproteinases/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Cartilagem Articular/citologia , Técnicas de Cultura de Células , Condrócitos/imunologia , Condrócitos/metabolismo , Colágeno Tipo II/efeitos dos fármacos , Colágeno Tipo II/metabolismo , Feminino , Glicosaminoglicanos/metabolismo , Humanos , Imuno-Histoquímica , Inflamação , Interleucina-1beta/farmacologia , Interleucina-8/efeitos dos fármacos , Interleucina-8/imunologia , Interleucinas/imunologia , Articulação do Joelho/citologia , Masculino , Metaloproteinase 13 da Matriz/efeitos dos fármacos , Metaloproteinase 13 da Matriz/metabolismo , Metaloproteinases da Matriz/metabolismo , Pessoa de Meia-Idade , Osteoartrite do Joelho/imunologia , Reação em Cadeia da Polimerase , Receptores Adrenérgicos/metabolismo , Receptores Adrenérgicos alfa/efeitos dos fármacos , Receptores Adrenérgicos alfa/metabolismo , Receptores Adrenérgicos beta/efeitos dos fármacos , Receptores Adrenérgicos beta/metabolismo , Inibidores Teciduais de Metaloproteinases/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA